Score for neonatal acute physiology and phlebotomy blood loss predict erythrocyte transfusions in premature infants

Archives of Pediatrics and Adolescent Medicine

Volumn 151, Issue 1, 1997, Pages 27-31

  Kling, Pamela J ^a,b,c   Sullivan, Tara M ^a   Leftwich, Margaret E ^a   Roe, Denise J ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; NEWBORN MONITORING; PHLEBOTOMY; PREMATURITY; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0031025719     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1997.02170380031005     Document Type: Article

References (25)

1. Strauss RG. Transfusion therapy in neonates. AJDC. 1991;145:904-911.
2. Strauss RG. Erythropoietin in the pathogenesis and treatment of neonatal anemia. Transition. 1995;35:68-73.
3. Maier RF, Obladen M, Scigalla P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med. 1994;330:1173-1178.
4. Shannon KM, Keith JF, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics. 1995;95:1-10.
5. Ohls R, Osborne K, Christensen R. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr. 1995;126:421-426.
6. Messer J, Schieffer F, Donato L, Haddad J. Which infants are best candidates for treatment with RH erythropoietin (RHEPO) in anemia of prematurity? Pediatr Res. 1994;35:241A. Abstract.
7. Asch J, Wedgwood J. Is there a role for erythropoietin treatment in VLBW infants? Pediatr Res. 1995;37:279A. Abstract.
8. Ringer SA, Richardson DK, Sacher RA, et al. Determinants of blood use in neonatal intensive care: a multivariate model. Pediatr Res. 1992;312:219A. Abstract.
9. Levy GJ, Strauss RG, Hume H, et al. National Survey of Neonatal Transfusion Practices, I: red blood cell therapy. Pediatrics. 1993;91:523-529.
10. Bifano EM, Miggiani W, Parker P. Impact of transfusion guidelines on transfusion practices in premature infants. Pediatr Res. 1994;35:216A. Abstract.
11. Richardson DK, Gray JE, McCormick MC, Workman K, Goldmann DA. Score for neonatal acute physiology: a physiologic severity index for neonatal intensive care. Pediatrics. 1993;91:617-623.
12. Richardson DK, Phibbs CS, Gray JE, McCormick MC, Workman-Daniels K, Goldmann DA. Birth weight and illness severity: independent predictors of NICU mortality. Pediatrics. 1993;91:969-975.
13. Gray JE, Richardson DK, McCormick MC, Goldmann DA. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics. 1995;95:225-230.
14. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules: applications and methodoiogical standards. N Engl J Med. 1985;313:793-799.
15. Wilimas J, Grist W. Erythropoietin - not yet a standard treatment for anemia of prematurity. Pediatrics. 1995;95:9-10.
16. Strauss RG. Erythropoietin and neontatal anemia. N Engl J Med. 1994;330:1227-1228.
17. Escobar GJ, Fischer A, Li DK, Kremers R, Armstrong MA. Score for neonatal acute physiology: validation In three Kaiser Permanente neonatal intensive care units. Pediatrics. 1995;96:918-922.
18. Gray JE, Richardson DK, McCormick MC, Workman-Daniels K, Goldmann DA. Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index. Pediatrics. 1992;90:561-567.
19. Pollack MM, Yeh TS, Ruttimann UE, Holbrook PR, Fields AI. Validation of a physiologic stability index for use in critically ill infants and children. Pediatr Res. 1984;18:445-451.
20. Georgieff MK, Mills MM, Bhatt P. Validation of two scoring systems which assess the degree of physiologic instability in critically ill newborn infants. Crit Care Med. 1989;17:17-21.
21. Cockburn F, Cooke RWI, Gamsu HR, et al. The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet. 1993;342:193-198.
22. Palta M, Gabbert D, Fryback D, et al. Development and validation of an index for scoring baseline respiratory distress in the very low birthweight neonate. Pediatrics. 1990;86:714-721.
23. Sinkin RA, Cox C, Phelps DL. Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics. 1990;86:728-736.
24. Fain J, Hilsenrath PE, Widness JA, Strauss RG, Mutnick AH. A cost analysis comparing erythropoietin and red cell transfusions in the anemia of prematurity. Transfusion. 1995;35:936-943.
25. Kumar P, Chinnakrishnan R, Shankaran S, Lucena J. Use of erythropoietin (EPO) for anemia of prematurity in very low birthweight infants does not alter the rate of weight gain or duration of hospitalization. Pediatr Res. 1994;35:234A. Abstract.